Ireland
--:--IST
Latest
Clinical Trials in France / NCT07512830
Recruiting Not applicable

Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography

NCT07512830 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-02-18
Last updated
2026-04-06

Condition(s) studied

Cardio Vascular Disease

Investigational drug(s) / intervention(s)

conversational hypnosis

conversational hypnosis: Local anaesthesia will be administered by a nurse. A first cardiologist (a doctor trained in hypnosis) will be present to explain the procedure to the patient using conversational hypnosis. Once all the information has been provided and understood, he will use hypnosis to attempt to induce a trance (see section 1.4 Procedure). A second cardiologist (operator) will perform the examination. As in the control group, the cardiologist trained in hypnosis will assist the operating cardiologist during the examination and may perform the examination himself if the first operator fails.

Study summary

Transoesophageal echocardiography (TOE) is a routine cardiology examination that is performed in most cases under local anaesthesia and is recommended for many indications.The objective of our study will be to evaluate the expected beneficial effect of using conversational hypnosis and hypnosis during a transoesophageal ultrasound examination performed directly in the examination room by the cardiologist conducting the examination.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Patient aged ≥ 18 years old * Patient requiring a transoesophageal ultrasound scan under local anaesthetic. * Patient affiliated to a health insurance scheme * French-speaking patient * Patient who has given their free, informed and express verbal consent Exclusion Criteria: Patient with a contraindication to transoesophageal ultrasound (significant radiation exposure to the chest, oesophageal pathology with risk of bleeding) * Patients with known schizophrenia or known psychiatric illness (documented in medical records) * Patients with known dementia or known cognitive impairment (documented in medical records) * Patients already included in an interventional research protocol * Patients under guardianship or curatorship * Patients deprived of their liberty * Patients under judicial protection * Pregnant or breastfeeding patients

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpital Paris Saint Joseph Paris Île-de-France Region Recruiting

More Fondation Hôpital Saint-Joseph trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07512830 on ClinicalTrials.gov ↗ ← All trials in France